Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | EXP | | 6480464 | 2 more ... | CTD | PMID:19414516 | 1,2-dimethylhydrazine | multiple interactions | ISO | Stmn4 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of STMN4 mRNA | CTD | PMID:22206623 | 15-acetyldeoxynivalenol | increases expression | ISO | STMN4 (Homo sapiens) | 6480464 | 15-acetyldeoxynivalenol results in increased expression of STMN4 mRNA | CTD | PMID:23792671 | 17alpha-ethynylestradiol | multiple interactions | ISO | Stmn4 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STMN4 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Stmn4 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STMN4 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of STMN4 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Stmn4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of STMN4 mRNA | CTD | PMID:19465110 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Stmn4 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of STMN4 mRNA | CTD | PMID:20188158 | 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in increased expression of STMN4 mRNA | CTD | PMID:19162173 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Stmn4 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of STMN4 mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Stmn4 (Mus musculus) | 6480464 | bisphenol S affects the methylation of STMN4 gene | CTD | PMID:31683443 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STMN4 mRNA | CTD | PMID:36041667 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Stmn4 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of STMN4 exon | CTD | PMID:33297965 | 5-aza-2'-deoxycytidine | affects expression | ISO | STMN4 (Homo sapiens) | 6480464 | Decitabine affects the expression of STMN4 mRNA | CTD | PMID:23300844 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of STMN4 mRNA | CTD | PMID:28959563 | acrylamide | decreases expression | ISO | STMN4 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of STMN4 mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases expression | ISO | STMN4 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of STMN4 mRNA | CTD | PMID:22100608 | all-trans-retinoic acid | multiple interactions | ISO | Stmn4 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of STMN4 mRNA | CTD | PMID:36189433 | amitriptyline | increases expression | EXP | | 6480464 | Amitriptyline results in increased expression of STMN4 mRNA | CTD | PMID:22341215 | amphotericin B | increases expression | ISO | STMN4 (Homo sapiens) | 6480464 | Amphotericin B analog results in increased expression of STMN4 mRNA | CTD | PMID:28534445 | arsenite(3-) | decreases methylation | ISO | STMN4 (Homo sapiens) | 6480464 | arsenite results in decreased methylation of STMN4 promoter | CTD | PMID:23974009 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of STMN4 mRNA | CTD | PMID:36841081 | benzo[a]pyrene | increases methylation | ISO | STMN4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of STMN4 exon | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | STMN4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of STMN4 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | affects methylation | ISO | STMN4 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of STMN4 promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | STMN4 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of STMN4 mRNA | CTD | PMID:31163220 | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STMN4 mRNA | CTD | PMID:31199487 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of STMN4 mRNA | CTD | PMID:25181051 and PMID:34947998 | bisphenol A | decreases expression | ISO | Stmn4 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of STMN4 mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STMN4 mRNA | CTD | PMID:36041667 | bisphenol F | decreases expression | ISO | Stmn4 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of STMN4 mRNA | CTD | PMID:30951980 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STMN4 mRNA | CTD | PMID:36041667 | butanal | increases expression | ISO | STMN4 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of STMN4 mRNA | CTD | PMID:26079696 | Butylbenzyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STMN4 mRNA | CTD | PMID:31199487 | cadmium dichloride | decreases expression | ISO | STMN4 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of STMN4 mRNA | CTD | PMID:21457566 | cisplatin | affects expression | ISO | STMN4 (Homo sapiens) | 6480464 | Cisplatin affects the expression of STMN4 mRNA | CTD | PMID:23300844 | cytarabine | increases response to substance | ISO | STMN4 (Homo sapiens) | 6480464 | STMN4 results in increased susceptibility to Cytarabine | CTD | PMID:21755009 | dibutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STMN4 mRNA | CTD | PMID:31199487 | diethyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STMN4 mRNA | CTD | PMID:31199487 | diisobutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STMN4 mRNA | CTD | PMID:31199487 | diisononyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STMN4 mRNA | CTD | PMID:31199487 | entinostat | decreases expression | ISO | STMN4 (Homo sapiens) | 6480464 | entinostat results in decreased expression of STMN4 mRNA | CTD | PMID:27188386 | ethanol | affects expression | ISO | Stmn4 (Mus musculus) | 6480464 | Ethanol affects the expression of STMN4 mRNA | CTD | PMID:30319688 | ethanol | affects splicing | ISO | Stmn4 (Mus musculus) | 6480464 | Ethanol affects the splicing of STMN4 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Stmn4 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of STMN4 mRNA | CTD | PMID:22206623 | methylmercury chloride | decreases expression | ISO | STMN4 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of STMN4 mRNA | CTD | PMID:34089799 | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Stmn4 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of STMN4 mRNA | CTD | PMID:36189433 | mono(2-ethylhexyl) phthalate | decreases expression | ISO | STMN4 (Homo sapiens) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of STMN4 mRNA | CTD | PMID:36314267 | Muraglitazar | decreases expression | EXP | | 6480464 | muraglitazar results in decreased expression of STMN4 mRNA | CTD | PMID:21515302 | N-Nitrosopyrrolidine | increases expression | ISO | STMN4 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in increased expression of STMN4 mRNA | CTD | PMID:32234424 | niclosamide | increases expression | ISO | STMN4 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of STMN4 mRNA | CTD | PMID:36318118 | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of STMN4 mRNA | CTD | PMID:33484710 | paracetamol | affects expression | ISO | Stmn4 (Mus musculus) | 6480464 | Acetaminophen affects the expression of STMN4 mRNA | CTD | PMID:17562736 | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of STMN4 mRNA | CTD | PMID:32680482 | progesterone | increases expression | ISO | Stmn4 (Mus musculus) | 6480464 | Progesterone results in increased expression of STMN4 mRNA | CTD | PMID:22238285 | sodium arsenite | decreases expression | ISO | Stmn4 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of STMN4 mRNA | CTD | PMID:37682722 | Tesaglitazar | decreases expression | EXP | | 6480464 | tesaglitazar results in decreased expression of STMN4 mRNA | CTD | PMID:21515302 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of STMN4 mRNA | CTD | PMID:21515302 | valproic acid | affects expression | ISO | STMN4 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of STMN4 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | STMN4 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of STMN4 mRNA | CTD | PMID:23179753 and PMID:25192806 | valproic acid | increases expression | ISO | STMN4 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of STMN4 mRNA | CTD | PMID:28001369 | |